Free Trial
ASX:HLS

Healius (HLS) Stock Price, News & Analysis

Healius logo

About Healius Stock (ASX:HLS)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
2.33 million shs
Average Volume
N/A
Market Capitalization
A$1.01 billion
P/E Ratio
N/A
Dividend Yield
4.46%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive HLS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Healius and its competitors with MarketBeat's FREE daily newsletter.

HLS Stock News Headlines

Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.
Spheria Reduces Stake in Healius Limited
See More Headlines

HLS Stock Analysis - Frequently Asked Questions

Healius Limited (ASX:HLS) announced its quarterly earnings data on Friday, February, 15th. The company reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by $0.06. Healius had a negative trailing twelve-month return on equity of 61.77% and a negative net margin of 36.98%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Healius investors own include bluebird bio (BLUE), Argonaut Gold (AR), Athene (ATH), BELLUS Health (BLU), Esperion Therapeutics (ESPR), Fortress Biotech (FBIO) and Forte Biosciences (FBRX).

Company Calendar

Last Earnings
2/15/2019
Ex-Dividend for 5/22 Dividend
5/08/2025
Record date for 5/22 Dividend
5/22/2025
Dividend Payable
5/22/2025
Today
7/09/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
ASX:HLS
CIK
N/A
Fax
N/A
Employees
10,500
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
-0.94
Net Income
-A$636 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
A$1.75 billion
Price / Cash Flow
12.26
Book Value
A$0.88 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
A$1.01 billion
Optionable
Not Optionable
Beta
0.73
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (ASX:HLS) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners